Foundayo 2.5 mg tablets deliver orforglipron, a once-daily oral GLP-1 receptor agonist developed by Eli Lilly for medically supervised weight management in eligible adults. Approved by the Emirates Drug Establishment and available in the UAE, this prescription-only pill offers a needle-free alternative to injectable GLP-1 therapies. The 2.5 mg strength is the second titration step, taken after the 0.8 mg starting dose as part of a gradual, doctor-guided schedule.

How Foundayo Works

Orforglipron activates GLP-1 receptors in the brain and gut, the same appetite-regulating pathways your body uses after eating. By mimicking the natural GLP-1 hormone, it helps reduce hunger, increase feelings of fullness, and slow how quickly the stomach empties. This supports better control over food intake and portion sizes when combined with a reduced-calorie diet and increased physical activity.

Important Safety Information

Foundayo is a prescription-only medicine dispensed against a valid UAE prescription and must be used under medical supervision. It carries a boxed warning for the risk of thyroid C-cell tumors and should not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is not for use during pregnancy or breastfeeding, is not approved for children, and should not be combined with other GLP-1 receptor agonists. Common side effects are mainly gastrointestinal, including nausea, constipation, diarrhea, and vomiting, and usually ease as the body adjusts. Tell your doctor about all medicines you take and any history of pancreatitis, gallbladder, kidney, or gastrointestinal conditions. Consult your healthcare provider before starting Foundayo to confirm it is right for you.

Each tablet in this pack contains 2.5 mg of orforglipron, a small-molecule, non-peptide GLP-1 receptor agonist. Unlike peptide-based GLP-1 medicines such as semaglutide, orforglipron stays stable in tablet form and is absorbed without food or water restrictions, making it the only oral GLP-1 pill that can be taken at any time of day.

• Active ingredient: orforglipron 2.5 mg

• Drug class: GLP-1 receptor agonist (oral)

• Manufacturer: Eli Lilly

• Inactive ingredients: microcrystalline cellulose, copovidone, crospovidone, magnesium stearate, sodium carbonate; film coating of polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide, and ferric oxide yellow

Always take Foundayo exactly as prescribed by your doctor, one tablet once daily. Swallow the tablet whole with no need to time it around meals; do not break, crush, or chew it. The 2.5 mg dose is a titration step, not a maintenance dose. Your prescriber will adjust your dose at intervals of at least 30 days based on your response and tolerability. Never take more than one tablet per day.